SHIPPING UPDATE
Journal orders are currently subject to delays
While we upgrade our fulfilment system. We endeavour to ship Journal orders as soon as possible.
Pharmacological Research - Reports
Annual issues: 2 volumes, 2 issues
- ISSN: 2950-2004
Pharmacological Research - Reports (PREREP) is a sound-science journal dedicated to publishing a wide range of topics in biomedical sciences that move the pharmacology fie… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quotePharmacological Research - Reports (PREREP) is a sound-science journal dedicated to publishing a wide range of topics in biomedical sciences that move the pharmacology field forward. It provides a venue through which researchers can rapidly communicate original investigation, with stronger focus on methodological rigor and transparency in reporting, rather than on the perceived impact of the novelty of the findings.
Our broad scope covers:
In vitro and in vivo studies assessing the effects of bioactive compounds (synthetic or derived from natural sources) and their mechanism of action;
Drug development (target identification and validation, PK/PD, preclinical and toxicological assessments);
Experimental validation and new methods in pharmacology;
Negative findings based on hypothesis-driven and well-controlled experiments;
Studies focusing on reproducibility in pharmacology;
Real world evidence on medical treatments;
Case studies, Phase I and II studies
Review articles with a systematic approach and/or critical appraisal of the published literature
Research reports on educational initiatives in pharmacology
Pharmacological Research - Reports (PREREP) is an independent companion journal and a spin-off from Pharmacological Research (Pharmacol Res). It is part of the Pharmacological Research Family of Journals. PREREP has an independent editorial team, a different publishing model (hybrid), and will be indexed differently.
- ISSN: 2950-2004
- Volume 2
- Issue 2
Read the Pharmacological Research - Reports Guide for Authors, Open Access policy, and latest articles on ScienceDirect